Literature DB >> 27856516

Effect of the systemic inflammatory response, as provoked by elective orthopaedic surgery, on HbA1c.

Andrew J Chadburn1, Elizabeth Garman1, Raad Abbas2, Anu Modupe1, Clare Ford1, Osmond L Thomas2, Sanjiv Chugh2, Shreeram Deshpande2, Rousseau Gama1,3.   

Abstract

Background In acutely ill patients with new onset hyperglycaemia, plasma glucose cannot reliably distinguish between stress hyperglycaemia and undiagnosed diabetes mellitus. We, therefore, investigated the diagnostic reliability of glycated haemoglobin (HbA1c) in acute illness by prospectively evaluating the effect of the systemic inflammatory response, as provoked by elective orthopaedic surgery, on HbA1c. Methods HbA1c and serum C-reactive protein concentrations were compared before and two days after elective knee or hip surgery in 30 patients without diabetes. C-reactive protein was used to assess the systemic inflammatory response. Results The mean (standard deviation) serum C-reactive protein increased following surgery (4.8 [7.5] vs. 179.7 [61.9] mg/L; P<0.0001). HbA1c was similar before and after surgery (39.2 [5.4] vs. 38.1 [5.1] mmol/moL, respectively; P = 0.4363). Conclusions HbA1c is unaffected within two days of a systemic inflammatory response as provoked by elective orthopaedic surgery. This suggests that HbA1c may be able to differentiate newly presenting type 2 diabetes mellitus from stress hyperglycaemia in acutely ill patients with new onset hyperglycaemia.

Entities:  

Keywords:  HbA1c; Systemic inflammatory response; acute illness

Mesh:

Substances:

Year:  2017        PMID: 27856516     DOI: 10.1177/0004563216682536

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  1 in total

1.  Fructosamine: A Negative Acute Phase Reactant.

Authors:  Elizabeth Garman; Andrew J Chadburn; Raad Abbas; Anu Modupe; Osmond L Thomas; Sanjiv Chugh; Shreeram Deshpande; Clare Ford; Rousseau Gama
Journal:  J Diabetes Sci Technol       Date:  2017-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.